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Abstract 
Human placental ATP diphosphohydrolase (ATP-DPH), has been previously characterized as an azide-sensitive, Ca 2+- or Mg2+-de - 
pendent triphospho- and diphosphonucleosidase which migrates as an 82 kDa protein band on SDS-PAGE (Christoforidis, S. et al. (1995) 
Eur. J. Biochem. 234, 66-74). In this paper we have studied the subcellular localization of placental ATP-DPH by differential 
centrifugation and flotation experiments. Using specific enzymatic markers it was found that ATP-DPH is localized on plasma membrane. 
ATP-DPH was found to be a highly N-glycosylated protein which is a common post-translational modification of plasma membrane 
proteins. Extensive incubation of the native pure enzyme with N-glycosidase F resulted in the elimination of the 82 kDa form and the 
concurrent formation of a deglycosylated product of 57.5 kDa and four other intermediate products, indicating the presence of at least five 
N-glycosylation sites within the ATP-DPH molecule. The partially deglycosylated sample retained its activity in solution and in native gel 
electrophoresis and activity staining. 
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1. Introduction 
ATP diphosphohydrolase (ATP-DPH, apyrase, ATP- 
Dase, EC 3.6.1.5) hydrolyses triphospho- and diphospho- 
nucleosides to monophosphonucleosides at a similar rate in 
the presence of Ca 2+ or Mg 2+. 
Mammalian ATP-DPHs have been found to be glyco- 
proteins [1-3] mainly localized in plasma membranes [4-  
7]. In addition to the plasma membrane, the pancreatic 
enzyme was also detected in Golgi transsacules, and on 
zymogen granules [8,9]. ATP-DPH from bovine aorta (en- 
dothelial and smooth muscle cells) and trachea (non-vascu- 
lar smooth muscle cells) was characterized as an ecto-en- 
zyme [6,7]. 
In human placenta tri- and dinucleotidase activity was 
first reported by Cerletti et al. [10]. Later, an ADPase 
activity was detected [11,12] which was initially attributed 
to alkaline phosphatase [11]. We have previously reported 
the identification of an ATP-DPH activity sensitive to 
azide inhibition in human placenta and proposed that this 
activity is responsible for the hydrolysis of ADP in this 
tissue [13]. Kettlun et al. [14] described some properties of 
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human placental ATP-DPH. The enzyme was found to be 
a 64 kDa glycoprotein, activated by a soluble protein, and 
inhibited by another protein loosely bound to membranes. 
However, they did not detect sensitivity to azide. Recently, 
we have purified ATP-DPH from human placenta and 
characterized the purified enzyme as a glycoprotein with a 
molecular mass of 82 kDa on SDS-PAGE [1]. However, 
the functional significance of the carbohydrates on the 
activity of this enzyme is not yet known. The enzymatic 
activity is dependent on divalent cations Ca 2÷ or Mg 2+, 
and exhibits broad substrate specificity hydrolysing all 
triphospho- and diphosphonucleosides with a K m for ATP 
or ADP in the txmolar concentration. The optimum pH 
ranges between 7.5 and 8.0. NaN 3 and NaF have been 
found to inhibit the enzymatic activity. 
Glycosylation of proteins has been proposed to play a 
key role in the stabilization of protein conformation, pro- 
tection of proteins from proteases, modulation of protein 
functions, mediation of cell-matrix and cell-cell interac- 
tions and control of half-life of proteins [15]. Some en- 
zymes lose their activity upon deglycosylation, whereas 
others retain it [15]. Based on the above studies, it appears 
that the contribution of glycosylation on catalytic activity 
depends on the nature of the particular enzyme. 
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In the present study we have attempted to detect he 
subcellular localization of human placental ATP-DPH by 
conventional fractionation and flotation techniques. Fur- 
thermore, we report he type of glycosylation, and the role 
of the carbohydrates on the activity and the molecular 
weight of human placental ATP-DPH. 
2. Materials and methods 
2.1. Materials 
Human term placenta was obtained after normal deliv- 
ery, placed on ice and immediately processed. N-Glyco- 
sidase F (25 000 U/mg) and Triton X-100 were obtained 
from Boehringer Mannheim. Potato apyrase (625 U/mg) 
was purchased from Sigma Chemical Company. Other 
chemicals were of the best available commercial grade. 
2.2. Enzymatic assays 
2.2.1. ATP diphosphohydrolase 
ATP diphosphohydrolase was assayed according to 
Ames [16] at 30°C in 50 mM Tris-HC1, 1 mM MgCi 2, 1 
mM ADP (pH 7.5) (800 I~1). The reaction was started by 
the addition of enzyme and allowed to proceed for 10 min. 
Aliquots (300 txl) were assayed for inorganic phosphate at 
zero time and 10 min. The phosphate release was within 
the linear range, and the enzymatic activity was expressed 
in units of txmol Pi/min. 
2.2.2. 5'-Nucleotidase 
5'-Nucleotidase (5'-Nase) activity was assayed as indi- 
cated for ATP-DPH except hat 1 mM AMP was used as 
substrate. 
2.2.3. NADPH-cytochrome-c reductase 
NADPH-cytochrome-c reductase was assayed at room 
temperature as described [17] using 50 mM Tris-HC1 (pH 
7.5), 0.1 mM cytochrome c, 0.6 mM KCN and 0.1 mM 
NADPH (1 ml). Reduction of cytochrome c was moni- 
tored at 550 nm as a function of time. 
2.2.4. Cytochrome-c oxidase 
Cytochrome-c oxidase was assayed in 50 mM Tris-HC1 
(pH 7.5) and 0.05 mM reduced cytochrome c (1 ml) [18]. 
Reduced cytochrome c was prepared by dithionite treat- 
ment of oxidized cytochrome c. Excess of dithionite was 
removed by gel filtration on a G-25 column. Oxidation 
was followed by monitoring the decrease of absorbance at 
550 nm as a function of time. 
g fresh human term placenta was macerated with razor 
blades. Five volumes of 10 mM HEPES/NaOH, 0.25 M 
sucrose, 1 mM PMSF (phenylmethylsulfonyl fluoride) (pH 
7.5), were added and the suspension was homogenized in a 
Potter-Elvehjem homogenizer using a Heidolph stroker at 
a low speed. The homogenate was filtered through four 
layers of cheese-cloth and the filtrate (Homogenate) was 
centrifuged at 3500 RPM for 10 min in a SS-34 rotor 
(1000 × g) in a Sorvall RC-2B centrifuge at 4°C. 
The nuclear pellet (Ppte 1000 X g, Nu) was saved and 
the supernatant was recentrifuged asabove. The pellet was 
discarded and the supernatant was filtered through four 
double layers of cheesecloth (Sl) and centrifuged at l0 000 
RPM for l0 min in a SS-34 rotor (10000 X g). The 
mitochondrial pellet (Ppte l0 000 × g, Mt) was saved and 
the supernatant was centrifuged as above, The pellet ob- 
tained was discarded and the resulting supernatant (S 2) 
was further centrifuged at 100 000 X g, for 60 min in a 70 
Ti rotor in a Beckman ultracentrifuge, model L8-70. The 
high speed pellet, termed microsomal fraction (Ppte 
100000 X g, Mc) was saved and the supernatant was 
centrifuged as above. The resulting pellet was discarded, 
while the postmicrosomal supernatant (S3) was saved. 
2.4. Purification of plasma membranes (flotation experi- 
ment) 
Purification of plasma membranes was performed ac- 
cording to Aronson and Touster [20], with minor modifica- 
tions. Briefly, the mitochondrial fraction (Mt) and the 
microsomal pellet (Mc) were suspended separately in 5.8 
ml of 1.665 M sucrose in 10 mM HEPES/NaOH, 0.1 mM 
PMSF (pH 8.0). Each suspension was placed in the bottom 
of a 18-ml tube and overlayered by two layers of sucrose: 
8.7 ml 0.993 M sucrose in the above buffer was placed 
first, and on top 2.5 ml 0.25 M sucrose in the same buffer 
was layered. Tubes (17 mi total volume each) were cen- 
trifuged at 100000 X g, for 16 h in a SW 27 rotor at 4°C. 
At the end of the run, the tubes were fractionated from top 
to bottom into five fractions (3.0, 1.5, 6.0, 3.0 and 3.5 ml) 
for the microsomal pellet and into 6 fractions (2.5, 2.0, 5.5, 
3.5, 3.5 ml and pellet) in the case of the mitochondrial 
sample. 
2.5. Purification of human placental ATP-DPH 
Human placental ATP-DPH was purified according to 
Christoforidis et al. [1]. The specific activity of the final 
preparation was 20 ~mol/min per mg, and the activity 
was free of alkaline phosphatase. 
2.6. Protein determination 
2.3. Tissue fractionation 
Tissue fractionation was performed according to Fleis- 
cher and Kervina [19] with some modifications. Briefly, 50 
Protein was determined by the Lowry method [21]. 
Protein concentration in samples containing detergents was 
measured by the Bio-Rad assay according to Bradford [22]. 
Bovine serum albumin was used as a standard. 
S. Christoforidis et aL / Biochimica et Biophysica Acta 1282 (1996) 257-262 259 
2.7. Gel electrophoresis 3. Results 
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed according to Laemmli [23] and proteins 
were visualized by silver staining [24]. 
PAGE under native conditions was performed as previ- 
ously described [1] and gels were stained for activity as 
follows. The gels were washed with 25 mM 
HEPES/NaOH, 1 mM MgCI 2 (pH 7.5), 2 × 10 min and 
then incubated in the same medium containing 2 mM ADP 
or ATP and 2 mM Pb(NO3) 2 at 30°C. The reaction was 
stopped after 4 h by washing with distilled water and the 
precipitated Pb3(PO4) 2 was stained black with 1% ammo- 
nium sulfide [25]. 
2.8. Treatment of ATP-DPH with N-glycosidase F 
Pure ATP-DPH was treated with N-glycosidase F ac- 
cording to the manufacturer's instructions. Briefly, 2.5 Ixg 
placental ATP-DPH (as stated) was incubated with 2.34 
units N-glycosidase F (unless stated otherwise) in 20 mM 
HEPES/NaOH, 10 mM EDTA (pH 7.5), in a total volume 
of 20 Ixl, at 37°C for 12 h. Where indicated, incubation 
was continued with 2 additional portions of N-glycosidase 
F, at 12 and 24 h. Sodium azide and phosphate buffer 
which are present in the commercial preparation of N-gly- 
cosidase F, interfere with the enzymatic assay of ATP- 
DPH. They were removed by extensive dialysis of the 
incubation mixture in 2 × 2 1 of buffer containing 50 mM 
Tris-HCl, 1 mM MgC12 (pH 8.0). Prior to dialysis, 780 ill 
of the above buffer were added to the sample. When 
ATP-DPH activity was tested by native gel electrophoresis 
and activity staining, dialysis was omitted. 
Denaturation prior to deglycosylation was performed by 
boiling the enzyme for 5 min in the presence of 0.1% SDS. 
Subsequently, Triton X-100 was added to a final concen- 
tration of 0.5% to prevent denaturation of N-glycosidase F 
by SDS. 
3.1. Subcellular localization of ATP-DPH 
We have attempted to determine the subcellular local- 
ization of placental ATP-DPH by differential centrifuga- 
tion and flotation experiments. The tissue was fractionated 
according to the procedure of Fleischer and Kervina [19] 
and the activity of ATP-DPH in each subcellular fraction 
was followed in parallel with typical marker enzymes. The 
distribution of ATP-DPH was found to be identical to that 
of 5'-nucleotidase, a marker of plasma membrane [26], 
suggesting that ATP-DPH is localized on the cell mem- 
brane (Table 1). A loss of ATP-DPH and 5'-nucleotidase 
activities was observed when S 1 and S 2 fractions were 
centrifuged, with no parallel loss in protein. This result 
might be due to loss of lipids that stabilize these plasma 
membrane nzymes. Indeed, on addition of phosphatidyl- 
choline, ATP-DPH activity was found to be increased 
(unpublished observations). 
To obtain a pure population of plasma membranes and 
study further the localization of ATP-DPH, the microsomal 
pellet was fractionated by flotation as described in Section 
2. ATP-DPH activity was followed in parallel with enzyme 
marker activities. As shown in Fig. 1, fraction 2 contains 
5'-Nase and ATP-DPH activities at a similar yield, while it 
is free of mitochondria nd microsomes as judged by the 
absence of the corresponding enzymatic markers. The 
distribution of ATP-DPH and 5'-Nase in the other fractions 
is also similar. An identical pattern of 5'-Nase and ATP- 
DPH distribution was obtained when the mitochondrial 
fraction was fractionated by flotation (data not shown). 
These results support he notion that placental ATP-DPH 
is a plasma membrane nzyme. 
To compare ATP-DPH from plasma membranes with 
the purified enzyme, native gel electrophoresis and activity 
staining were used. Purified plasma membrane fraction 
(Fig. 2, panel ADP, lane 1) contained an activity with the 
Table 1 
Localization of ATP-DPH activity in human placental subcellular f actions 
Fraction Activity a % 
ATP-DPH 5'-Nucleotidase NADPH cytochrome-c reductase Cytochrome-c oxidase Protein b (mg) 
Homogenate 100 100 100 100 525 
Nu c 4 1 6 10 66 
S I 93 94 92 70 403 
Mt 23 24 39 81 66 
S 2 43 42 60 0 359 
Mc 25 27 26 1 60 
S 3 3 5 35 0 365 
Enzymatic activities were determined as described in Section 2. 
b Protein was measured by the Lowry method [21]. 
c Abbreviations of the subcellular f actions are defined in Section 2. 
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Fig. 1. Isolation of plasma membranes by flotation. Plasma membranes 
from microsomal pellet were purified by flotation as described in Section 
2. The purity of the preparation was assessed by determination of marker 
enzymes (5'-nucleotidase, NADPH-cytochrome-c reductase and cy- 
tochrome-c oxidase). Enzyme activities are expressed as percentage of 
the initial units. Note that fraction 2 is enriched in 5'-nucleotidase and 
ATP-DPH. Cytochrome-c oxidase activity of the microsomal fraction was 
negligible (see Table 1) and is not shown. 
same migration pattern as the pure enzyme (Fig. 2, panel 
ADP, lane 2). Both bands were diminished by NaN 3, a 
known inhibitor of ATP-DPH [1,2,4,5,7,8,13,27] (Fig. 2, 
panel ADP + NaN 3, lanes 1, 2), which further supports the 
presence of placental ATP-DPH in plasma membranes. 
The upper band of ADP degrading activity detected in the 
plasma membrane fraction was inhibited by L-phenyl- 
alanine, an inhibitor of alkaline phosphatase [28] (Fig. 2, 
panels ADP and ADP + L-Phe, lane 1), suggesting that this 
activity is due to alkaline phosphatase. The existence of 
ADP 
ADP ADP 
+ + 
NaN 3 L-Phe 
ATP-DPH 
i! iii i ii!il  !i iii!iiil i!  ii i!iiiil 
; L iiii~iiiiii!iiii!i ........................ 
1 2 1 2 1 2 
Fig. 2. Detection of ATP-DPH by native PAGE and activity staining in 
the plasma membrane fraction. Purified plasma membranes, fraction 2 
from the flotation experiment (10 t~g, lane 1) and pure enzyme (0.3 ~g, 
lane 2) were subjected to native PAGE and stained for activity using 1 
mM ADP, or ADP+20 mM NAN3, or ADP+40 mM L-phenylalanine. 
Note the activity of the plasma membrane fraction which comigrates with 
pure ATP-DPH and is inhibited by NaN 3. 
A 
82c , -  
B 
57.5 I:~ 
! 
1 2 3 1 2 3 4 5  
Fig. 3. Effect of N-glycosidase F on the molecular weight and on activity 
of native ATP-DPH. (A) Purified ATP-DPH (2.5 l~g, lane 1), pure native 
ATP-DPH (2.5 I~g) treated with 2.34 U N-glycosidase F for 12 h (lane 2), 
and pure native ATP-DPH (2.5 Ixg) treated for 36 h with additions of 3.9 
U N-glycosidase F at 0, 12 and 24 h (lane 3) were subjected to 10% 
SDS-PAGE and protein bands were detected by silver staining. Note the 
elimination of 82 kDa form after extensive deglycosylation (lane 3). The 
lower band seen in lanes 2 and 3 corresponds to N-glycosidase F (34.6 
kDa). (B) Pure ATP-DPH (0.014 U, 0.71 txg, lane 1), pure ATP-DPH 
(0.014 U, 0.71 ~zg) treated with N-glycosidase F (0.66 U) for 12 h (lane 
2), pure ATP-DPH (0.014 U, 0.71 I.zg) treated for 36 h with additions of 
1.1 U N-glycosidase F at 0, 12 and 24 h (lane 3), buffer of N-glycosidase 
F (lane 4) and potato apyrase (0.16 i~g, 0.1 U, lane 5) were subjected to 
PAGE under native conditions and activity stained using ADP as sub- 
strate as described in Section 2. 
this enzyme in the preparation is consistent with the 
identification of the fraction as plasma membrane, since 
alkaline phosphatase is known to be localized in the 
cellular membrane anchored via glycosylphosphatidylinos- 
itol [29,30]. 
3.2. Effect of glycosylation on ATP-DPH activity 
We have previously shown that human placental ATP- 
DPH is glycosylated [1]. In the present study we tested the 
type of glycosylation and its effect on the molecular 
weight and the activity of ATP-DPH. First, we established 
the optimal conditions for deglycosylation of the native 
enzyme. Treatment of native ATP-DPH (Fig. 3A, lane 1) 
with N-glycosidase F for 12 h, resulted in a shift of the 
molecular weight from 82 000 to 80 000 and the appear- 
ance of a minor band of 57 500 which suggests that only a 
very small portion of carbohydrate was removed (Fig. 3A, 
lane 2). Extension of the incubation time to 36 h with two 
more additions of N-glycosidase F eliminated completely 
the 82 kDa glycosylated form, and resulted in the forma- 
tion of the 57.5 kDa deglycosylated product with the 
concurrent appearance of four other intermediate forms of 
ATP-DPH (Fig. 3A, lane 3). This result suggests the 
existence of at least five glycosylated Asn residues in the 
polypeptide chain of ATP-DPH. Complete deglycosylation 
of ATP-DPH was achieved using denatured ATP-DPH 
(boiled in the presence of 0.1% SDS) as substrate of 
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Table 2 
Effect of N-glycosidase F treatment on the activity of ATP-DPH 
Conditions ATP-DPH activity, % 
N-glycosidase F-treated Control 
0 h 100 100 
36 h at 37°C - 76 
36 h at 37°C and Experiment 1 57 45 
then dialysis at 0°C 
2 75 61 
3 66 53 
Average 66 53 
Pure ATP-DPH (0.014 U, 0.71 Ixg) was incubated for 36 h at 37°C in the 
absence (control) or in the presence of N-glycosidase F with additions of 
1.1 units of N-glycosidase F at 0, 12 and 24 h of incubation. 
gates that are not resolved by native gel electrophoresis 
under mild detergent conditions. 
However, despite the peculiar migration behavior, all 
samples show the same intensity, consistent with the re- 
sults shown in Table 2, suggesting that partial deglycosyla- 
tion has no significant effect on the activity of ATP-DPH. 
The lower band seen in Fig. 3B (lanes 2 and 3) is due to 
the phosphate ions present in the N-glycosidase F prepara- 
tion (Fig. 3B, lane 4). Potato apyrase, which also hydroly- 
ses ADP [31], was used as a control for the resolution 
efficiency of the native gel (Fig. 3B, lane 5). 
4. Discussion 
N-glycosidase F. This treatment resulted in the formation 
of a unique product of 57.5 kDa, which is identical with 
the lower molecular weight form obtained in the partially 
deglycosylated sample (data not shown). Judging by the 
decrease of the molecular weight of ATP-DPH (from 82 to 
57.5 kDa) after treatment with N-glycosidase F, it is 
concluded that placental ATP-DPH is approx. 30% glyco- 
sylated. 
The activity of the partially deglycosylated sample was 
tested as described in Section 2. Both glycosidase-treated 
and non-treated samples were dialysed to eliminate azide 
and phosphates which interfere with the assay. 
After dialysis the N-glycosidase F-treated enzyme and 
the control sample retained 66% and 53% of their activity 
respectively. An independent control of ATP-DPH incu- 
bated at 37°C for 36 h (no dialysis) retained 76% of its 
activity. These data, summarized in Table 2, suggest hat 
the deglycosylated nzyme retains its activity. 
The effect of deglycosylation on the activity of ATP- 
DPH was also tested using native gel electrophoresis and 
activity staining. Native ATP-DPH (Fig. 3B, lane 1), ATP- 
DPH treated with N-glycosidase F for 12 h or 36 h (with 
two more additions of glycosidase F) stained as a single 
band (Fig. 3B, lanes 2 and 3 respectively) which migrates 
with the same mobility as the untreated enzyme. The 
migration profile of these bands seems puzzling since the 
above samples consist of different molecular weight forms 
of ATP-DPH (see Fig. 3A). A possible xplanation for this 
result could be that N-glycosidase F removes carbo- 
hydrates with negative charge and creates a less negatively 
charged product and a lower molecular weight protein. 
Such a modification has opposite ffects on the parameters 
which influence the mobility of a protein on a native gel 
(charge and size), and may explain the observation that the 
partially deglycosylated enzyme has the same migration 
pattern as the native one. On the other hand, since we deal 
with a membrane protein, another interpretation for the 
migration pattern could be that the purified enzyme, as 
well as the partially deglycosylated sample, form aggre- 
In the present communication two lines of evidence 
show that human placental ATP-DPH is a plasma mem- 
brane enzyme. First, identical distribution pattern of ATP- 
DPH and 5'-Nase activity is seen in the fractions obtained 
after differential centrifugation f human placenta. Second, 
purified plasma membrane fraction was found to contain 
ATP-DPH activity. The distribution of both enzymes in the 
subcellular fractions was not as expected compared to the 
liver plasma membrane markers [19]. This could be due to 
the homogenization procedure which yields various sizes 
of plasma membrane fragments precipitable at 10000 X g 
and 100000 X g [19], as well as to the peculiarity of the 
placental tissue. 
ATP diphosphohydrolase from other sources has been 
mainly localized on the plasma membrane [4-7] with the 
exception of the pancreatic enzyme which was also de- 
tected in Golgi transsacules and on zymogen granules of 
the acinar cells of pig pancreas [8,9]. The location of 
ATP-DPH on plasma membranes i consistent with the 
proposed role of this enzyme in the prevention of blood 
clotting [32,33]. Besides, the placental enzyme [1] exhibits 
striking similarities with vascular ATP-DPH from umbili- 
cal vessels [34]. Vascular ATP-DPH from bovine aorta has 
been characterized as an ecto-enzyme [6]. The common 
properties concern the molecular weight, glycosylation, 
substrate specificity, sensitivity to various inhibitors and 
detergents, and dependence on divalent cations. In addi- 
tion, we have observed that both activities migrate with the 
same mobility in native PAGE (data not shown). Based on 
the similarity between these enzymes and the location of 
the placental ATP-DPH on plasma membranes, we postu- 
late that the placental activity may also be an ecto-enzyme. 
ATP-DPH from human placenta (82 kDa) has been 
previously characterized as a glycoprotein [1]. In this 
study, extensive incubation of this enzyme with N-glyco- 
sidase F resulted in the elimination of the fully glyco- 
sylated 82 kDa enzyme, and formation of a 57.5 kDa 
limiting product and four other intermediate forms. The 
partially deglycosylated sample of ATP-DPH was found to 
retain its enzymatic activity. Complete deglycosylation f
native ATP-DPH proved to be a difficult task, also re- 
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ported for other glycoproteins [35,36]. In contrast, dena- 
tured ATP-DPH was efficiently deglycosylated to yield a 
single band of 57.5 kDa identical to the limiting product of 
the partially deglycosylated sample. The shift of the 
molecular weight upon treatment with N-glycosidase F
shows that the molecule of ATP-DPH is approx. 30% 
glycosylated. A similar degree of glycosylation was re- 
ported for the ATP-DPH from bovine spleen [3]. A number 
of reports deal with the role of the glycosylation on the 
catalytic activity of enzymes. However, no general rule 
seems to exist so far. Some enzymes require the carbo- 
hydrates for their activity while in others the sugar part 
was not found necessary for their function [15]. Therefore, 
the functional significance of the existence of the sugars in 
placental ATP-DPH remains to be established. 
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